nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Toothache—Varenicline—nicotine dependence	0.0704	0.131	CcSEcCtD
Aclidinium—Dysphonia—Varenicline—nicotine dependence	0.0521	0.097	CcSEcCtD
Aclidinium—Diabetes mellitus—Varenicline—nicotine dependence	0.0357	0.0666	CcSEcCtD
Aclidinium—Osteoarthritis—Varenicline—nicotine dependence	0.0311	0.058	CcSEcCtD
Aclidinium—Urinary retention—Varenicline—nicotine dependence	0.0296	0.0551	CcSEcCtD
Aclidinium—Nasopharyngitis—Varenicline—nicotine dependence	0.0278	0.0518	CcSEcCtD
Aclidinium—Infestation NOS—Varenicline—nicotine dependence	0.024	0.0447	CcSEcCtD
Aclidinium—Infestation—Varenicline—nicotine dependence	0.024	0.0447	CcSEcCtD
Aclidinium—Sinusitis—Varenicline—nicotine dependence	0.0225	0.0419	CcSEcCtD
Aclidinium—Urinary tract disorder—Varenicline—nicotine dependence	0.0212	0.0396	CcSEcCtD
Aclidinium—Urethral disorder—Varenicline—nicotine dependence	0.0211	0.0393	CcSEcCtD
Aclidinium—Eye disorder—Varenicline—nicotine dependence	0.0201	0.0375	CcSEcCtD
Aclidinium—Mediastinal disorder—Varenicline—nicotine dependence	0.0194	0.0361	CcSEcCtD
Aclidinium—Vision blurred—Varenicline—nicotine dependence	0.0176	0.0329	CcSEcCtD
Aclidinium—Cough—Varenicline—nicotine dependence	0.0163	0.0305	CcSEcCtD
Aclidinium—Dry mouth—Varenicline—nicotine dependence	0.0156	0.0291	CcSEcCtD
Aclidinium—Infection—Varenicline—nicotine dependence	0.0152	0.0283	CcSEcCtD
Aclidinium—Nervous system disorder—Varenicline—nicotine dependence	0.015	0.0279	CcSEcCtD
Aclidinium—Tachycardia—Varenicline—nicotine dependence	0.0149	0.0278	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0132	0.0246	CcSEcCtD
Aclidinium—CHRM4—Monoamine GPCRs—DRD2—nicotine dependence	0.0128	0.0277	CbGpPWpGaD
Aclidinium—CHRM5—Monoamine GPCRs—DRD2—nicotine dependence	0.0123	0.0265	CbGpPWpGaD
Aclidinium—CHRM4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0108	0.0233	CbGpPWpGaD
Aclidinium—Diarrhoea—Varenicline—nicotine dependence	0.0105	0.0195	CcSEcCtD
Aclidinium—CHRM5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0103	0.0223	CbGpPWpGaD
Aclidinium—CHRM4—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0099	0.0214	CbGpPWpGaD
Aclidinium—Vomiting—Varenicline—nicotine dependence	0.00971	0.0181	CcSEcCtD
Aclidinium—Headache—Varenicline—nicotine dependence	0.00957	0.0178	CcSEcCtD
Aclidinium—CHRM5—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00948	0.0204	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00876	0.0189	CbGpPWpGaD
Aclidinium—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00866	0.0187	CbGpPWpGaD
Aclidinium—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00863	0.0186	CbGpPWpGaD
Aclidinium—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00855	0.0184	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00819	0.0177	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00777	0.0168	CbGpPWpGaD
Aclidinium—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00728	0.0157	CbGpPWpGaD
Aclidinium—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00726	0.0157	CbGpPWpGaD
Aclidinium—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00718	0.0155	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00667	0.0144	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00665	0.0144	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00659	0.0142	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.00628	0.0135	CbGpPWpGaD
Aclidinium—CHRM4—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00616	0.0133	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.00595	0.0128	CbGpPWpGaD
Aclidinium—CHRM4—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00591	0.0127	CbGpPWpGaD
Aclidinium—CHRM5—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.0059	0.0127	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00583	0.0126	CbGpPWpGaD
Aclidinium—CHRM5—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00566	0.0122	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00561	0.0121	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00538	0.0116	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—TAS2R16—nicotine dependence	0.0053	0.0114	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—TAS2R16—nicotine dependence	0.00508	0.011	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.005	0.0108	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.005	0.0108	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—GABRA4—nicotine dependence	0.0043	0.00928	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00415	0.00896	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00414	0.00893	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.00412	0.0089	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.0041	0.00885	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00408	0.0088	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00398	0.00859	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00397	0.00856	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00393	0.00848	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.00383	0.00827	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00369	0.00797	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00359	0.00775	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00358	0.00772	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00357	0.00769	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00353	0.00762	CbGpPWpGaD
Aclidinium—CHRM4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00343	0.00739	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00334	0.0072	CbGpPWpGaD
Aclidinium—CHRM5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00328	0.00708	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00326	0.00704	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.00313	0.00674	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00303	0.00654	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.003	0.00647	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00294	0.00634	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00287	0.00619	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00281	0.00607	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00276	0.00595	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.00275	0.00594	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TAS2R16—nicotine dependence	0.00272	0.00587	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—DRD2—nicotine dependence	0.00267	0.00576	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TAS2R16—nicotine dependence	0.00261	0.00562	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.0025	0.00539	CbGpPWpGaD
Aclidinium—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00248	0.00535	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00246	0.0053	CbGpPWpGaD
Aclidinium—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00237	0.00512	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—FGD1—nicotine dependence	0.00235	0.00507	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00231	0.00499	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0023	0.00497	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00228	0.00492	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—FGD1—nicotine dependence	0.00225	0.00486	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—OPRM1—nicotine dependence	0.00224	0.00482	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—OPRM1—nicotine dependence	0.00214	0.00462	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—FGD1—nicotine dependence	0.00214	0.00461	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00212	0.00458	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—FGD1—nicotine dependence	0.00205	0.00441	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00204	0.0044	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00203	0.00439	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00202	0.00436	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00201	0.00435	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.002	0.0043	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00198	0.00427	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00197	0.00426	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00195	0.00422	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00184	0.00396	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00183	0.00395	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00181	0.00391	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00178	0.00383	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00167	0.0036	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00167	0.00359	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00165	0.00356	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.00162	0.00349	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.00161	0.00347	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00159	0.00342	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.00158	0.00341	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00157	0.00338	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.00155	0.00334	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.00154	0.00332	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.00151	0.00325	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.0015	0.00324	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.00149	0.00321	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00144	0.00311	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.00144	0.0031	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00143	0.00309	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00143	0.00308	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.00142	0.00307	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00141	0.00305	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	0.00126	0.00273	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FGD1—nicotine dependence	0.00126	0.00272	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	0.00121	0.00261	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FGD1—nicotine dependence	0.00121	0.00261	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	0.00115	0.00248	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	0.00111	0.0024	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	0.0011	0.00237	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.00109	0.00235	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.00109	0.00234	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.00108	0.00234	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP2A7—nicotine dependence	0.00108	0.00234	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.00108	0.00233	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.00108	0.00232	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.00107	0.00231	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	0.00107	0.0023	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	0.000914	0.00197	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	0.000875	0.00189	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000852	0.00184	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000851	0.00184	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000849	0.00183	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000848	0.00183	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000841	0.00181	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.00084	0.00181	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000833	0.0018	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	0.00083	0.00179	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	0.000795	0.00171	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—WASF2—nicotine dependence	0.000785	0.00169	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000774	0.00167	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000771	0.00166	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000764	0.00165	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—WASF1—nicotine dependence	0.000753	0.00162	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—WASF2—nicotine dependence	0.000752	0.00162	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000752	0.00162	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000749	0.00162	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000742	0.0016	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—WASF1—nicotine dependence	0.000721	0.00156	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	0.000678	0.00146	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	0.000649	0.0014	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000616	0.00133	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000614	0.00132	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000608	0.00131	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000559	0.00121	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000558	0.0012	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000552	0.00119	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.00053	0.00114	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000528	0.00114	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000523	0.00113	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000508	0.0011	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000506	0.00109	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000501	0.00108	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD2—nicotine dependence	0.00049	0.00106	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD2—nicotine dependence	0.000469	0.00101	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000457	0.000986	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000456	0.000983	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000451	0.000973	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.00033	0.000713	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000329	0.000711	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000326	0.000704	CbGpPWpGaD
